Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stronger flu shot tested for seniors

NCT ID NCT04024228

Completed ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

Summary

This study tested whether a high-dose flu vaccine provides better protection for older adults than the standard-dose vaccine. Over 1,500 healthy volunteers aged 60 and older received either the high-dose or standard shot. Researchers measured the strength of the immune response and monitored safety for six months to see which vaccine worked better.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Investigational Site Number 0560001

    Ghent, BE-9000, Belgium

  • Investigational Site Number 0560002

    Wilrijk, 2610, Belgium

  • Investigational Site Number 2500001

    Gières, 38610, France

  • Investigational Site Number 2500003

    Pierre-Bénite, 69495, France

  • Investigational Site Number 2500004

    Paris, 75014, France

  • Investigational Site Number 2760001

    Essen, 45136, Germany

  • Investigational Site Number 2760002

    Oldenburg in Holstein, 23758, Germany

  • Investigational Site Number 2760003

    Berlin, 10629, Germany

  • Investigational Site Number 2760004

    Berlin, 13347, Germany

  • Investigational Site Number 2760005

    Berlin, 10787, Germany

  • Investigational Site Number 3800001

    Genova, IT-16132, Italy

  • Investigational Site Number 3800003

    Palermo, 90127, Italy

  • Investigational Site Number 5280001

    Utrecht, 3584 CX, Netherlands

  • Investigational Site Number 6160001

    Dębica, 39-200, Poland

  • Investigational Site Number 6160002

    Wola, 43-225, Poland

  • Investigational Site Number 6160003

    Siemianowice Śląskie, 41-103, Poland

  • Investigational Site Number 6160004

    Wroclaw, 50-452, Poland

Conditions

Explore the condition pages connected to this study.

HEALTHY VOLUNTEERS INFLUENZA IMMUNIZATION